(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

C26H40N2O2 — CID 155130841

IUPAC(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCC(O)(CCc1ccn[nH]1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C26H40N2O2/c1-24-12-9-19(29)16-17(24)4-5-20-21-6-7-23(25(21,2)13-10-22(20)24)26(3,30)14-8-18-11-15-27-28-18/h4,11,15,19-23,29-30H,5-10,12-14,16H2,1-3H3,(H,27,28)/t19-,20-,21-,22-,23-,24-,25-,26?/m0/s1
InChIKeyQPBVYMFIGUOGRV-BYBKDHMRSA-N
MW412.62 g/mol
LogP5.03
Rot. Bonds4

About (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 155130841) has the molecular formula C26H40N2O2 and a molecular weight of 412.62 g/mol. Its IUPAC name is (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
PubChem CID155130841
Molecular FormulaC26H40N2O2
Molecular Weight412.62 g/mol
Exact Mass412.31
IUPAC Name(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCC(O)(CCc1ccn[nH]1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C26H40N2O2/c1-24-12-9-19(29)16-17(24)4-5-20-21-6-7-23(25(21,2)13-10-22(20)24)26(3,30)14-8-18-11-15-27-28-18/h4,11,15,19-23,29-30H,5-10,12-14,16H2,1-3H3,(H,27,28)/t19-,20-,21-,22-,23-,24-,25-,26?/m0/s1
InChIKeyQPBVYMFIGUOGRV-BYBKDHMRSA-N
XLogP5.03
TPSA69.14 Ų
H-Bond Donors3
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms30
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500412.62
LogP ≤ 55.03
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 155130841) is (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is CC(O)(CCc1ccn[nH]1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The InChIKey is QPBVYMFIGUOGRV-BYBKDHMRSA-N. The full InChI is InChI=1S/C26H40N2O2/c1-24-12-9-19(29)16-17(24)4-5-20-21-6-7-23(25(21,2)13-10-22(20)24)26(3,30)14-8-18-11-15-27-28-18/h4,11,15,19-23,29-30H,5-10,12-14,16H2,1-3H3,(H,27,28)/t19-,20-,21-,22-,23-,24-,25-,26?/m0/s1.
What are the key properties of (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
(3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 412.62 g/mol, XLogP of 5.03, 4 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,8S,9S,10R,13S,14S,17S)-17-[2-hydroxy-4-(1H-pyrazol-5-yl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 155130841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).